Corbus Pharmaceuticals Holdings, Inc.
CRBP · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | – | $84,456 | $64,793 | $143,718 |
| - Cash | $26,983 | $20,044 | $18,900 | $17,198 |
| + Debt | $307 | $2,456 | $2,855 | $3,239 |
| Enterprise Value | – | $66,868 | $48,748 | $129,759 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | $0 | -$100 | -$15,642 | -$146 |
| % Margin | – | – | – | – |
| EBITDA | -$23,342 | -$17,562 | -$18,578 | -$9,384 |
| % Margin | – | – | – | – |
| Net Income | -$23,342 | -$17,662 | -$16,978 | -$9,530 |
| % Margin | – | – | – | – |
| EPS Diluted | -1.9 | -1.44 | -1.39 | -0.78 |
| % Growth | -31.9% | -3.6% | -78.2% | – |
| Operating Cash Flow | -$15,550 | -$16,599 | -$16,421 | -$10,942 |
| Capital Expenditures | $0 | $0 | $0 | $0 |
| Free Cash Flow | -$15,550 | -$16,599 | -$16,421 | -$10,942 |